| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.45 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |